Phase I trial of A 4250 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2015
At a glance
- Drugs A 4250 (Primary)
- Indications Cholestasis; Non-alcoholic steatohepatitis; Primary biliary cirrhosis; Pruritus
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors Albireo AB
- 12 Nov 2015 According to Albireo media release, the results of this study will be presented at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 2015.
- 02 Nov 2015 Results published in the Alimentary Pharmacology and Therapeutics
- 10 Feb 2015 New trial record